Critical role of microRNAs after global myocardial ischemia and reperfusuion

doi: 10.18081/2333-5106/015-07/451-467
American Journal of BioMedicine Volume 3, Issue 7, pages 451-467
Published: July 29, 2015

Renzo Grupper,  Ross Edward, Christian Walter, Eva Varnous


Myocardial ischemia reperfusion injury is a major problem in heart transplantation and its mechanism is still not fully known. MicroRNAs (miRNAs) are small, single-stranded RNA molecules which play an important role in posttranscriptional regulation of gene expression by inhibiting translation of target mRNAs. The objective of this study is to investigate the mechanistic role of miRNAs on global myocardial ischemia-reperfusion injury in mice. The mice heart was mounted in a Langendorff-type isolated heart perfusion system. The coronary effluent volume was measured at the various time intervals for a total of 120 min. Coronary flow rate (CFR, in ml · min−1 · g−1) was defined as the total volume collected during the reperfusion interval divided by the time, normalized by the heart wet weight (g), which was measured at the beginning of the experiment. The volume fraction of interstitial space (VFITS) in myocardial tissue was determined from H-E-stained sections by using the equation VFITS = (100% × area of interstitial space)/total tissue area. The mitochondrial cross-sectional area was measured. The number of fragmented mitochondria, the number of mitochondria with amorphous matrix densities or granular densities, and the total number of mitochondria studied in each group were counted. Further, The average LV dP/dt during 0–30, 30–60, 60–90, and 90–120 min of reperfusion was calculated from data continuously recorded during the corresponding reperfusion period. In conclusion the present data show that the miRNAs have a great potential as biomarker, therapeutic target, and led to significant new insights into the pathophysiology of global myocardial I/R, graft rejection.

Keywords: Myocardial ischemia reperfusion injury; Heart transplantation; MicroRNAs; Coronary flow rate



1. Liang, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007:166. [Abstract/Full-Text]

2. Engelman DT, Watanabe M, Engelman RM, et al. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg 1995;110:1047–1053. [PubMed]

3. Du T, Zamore PD: microPrimer. The biogenesis and function of microRNA. Development 2005;132(21):4645-4652. [PubMed]

4. Wan S, DeSmet JM, Barvais L, Golstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112: 806–811.

5. Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development 2005;132(21):4653-4662. [PubMed]

6. Eberhardt F, Mehlhorn U, Larose K, DeVivie ER, Dhein S. Structural myocardial changes after coronary artery surgery. Eur J Clin Invest 2000; 30: 938–946.

7. Austin EW, Yousif NG, Ao L, et al. Ghrelin reduces myocardial injury following global ischemia and reperfusion via suppression of myocardial inflammatory response. American Journal of BioMedicine 2013;1(2):38-48. [Abstract/Full-Text]

8. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988.

9. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122(1):6-7. [PubMed]

10. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004;14(10A):1902-1910. [PubMed]

11. Baskerville S, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. Rna 2005;11(3):241-247. [PubMed]

12. Bagga S, Bracht J, Hunter S, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005;122(4):553-563. [PubMed]

13. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908–913.

14. Chang L, Du JB, Gao LR, et al.  Effect of ghrelin on septic shock in rats. Acta Pharmacol Sin 2003; 24: 45–49.

15. Nagaya N, Uematsu M, Kojima M, et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001;104:1430–1435.

16. Chang L, Ren Y, Liu X, et al. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 2004; 43(2): 165-70

17. Locatelli V, Rjossoni G, Schweiger F, et al. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology 1999;140: 4024–4031.

18. Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior. J Clin Oncol 2006. [PubMed]

19. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature 2005;435(7043):828-833. [PubMed]

20. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285(2):H579–H588. [PubMed]

21. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 2011;301(5):H1723–H1741. [PubMed]

22. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357(11):1121–1135. [PubMed]

23. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004;432(7014):226-230. [PubMed]

24. Yousif NG, Ao L, Li J, Aly A, Austin E, Fullerton DA, Meng X. Myocardial tissue TLR4 plays a major role in mediating myocardial injury following cold ischemia and reperfusion through up-regulation of MCP-1. Journal of Surgical Research 2011;165(2):181. [Abstract]

Limited access article


limited access This article with limited access need to be buy, before continue with your purchase please read carefully the AJBM terms and conditions of purchase.

Purchase this article at rate $55.00 and received Full-Text/PDF
You will have online immediate access to article following the completion of this purchase and you may download and print a copy of each article for your personal use. Use the coding below to purchase your article as PDF by credit card, debit card, payball will be asked to supply your billing card information.


For any technique error please contact us and will be response to sending purchase article by email.

Thank you for visiting American Journal of BioMedicine.  * = Required fields

[gravityform id=”6″ name=”Feedback”]

Print Friendly, PDF & Email